Stryker Corporation $SYK Shares Sold by Raiffeisen Bank International AG

Key Points

• Raiffeisen Bank International AG reduced its Stryker stake by 8.5% in the second quarter, selling 8,678 shares and retaining 93,268 shares valued at approximately $30.8 million. Institutional investors collectively own 77.09% of the company.
• Analyst sentiment remains positive, with a consensus “Moderate Buy” rating and an average price target of $386.28, although several firms lowered their targets and Wolfe Research downgraded the stock to “Peer Perform.”
• Stryker exceeded quarterly earnings expectations, reporting $3.69 EPS and $6.59 billion in revenue, with revenue rising 9.4% year over year. The company also declared a quarterly dividend of $0.88 per share, while insiders have sold substantial shares in the past 90 days.

Raiffeisen Bank International AG cut its stake in Stryker Corporation (NYSE:SYK - Free Report) by 8.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 93,268 shares of the medical technology company's stock after selling 8,678 shares during the period. Raiffeisen Bank International AG's holdings in Stryker were worth $30,827,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. VanderPol Investments L.L.C. increased its stake in shares of Stryker by 1.4% in the fourth quarter. VanderPol Investments L.L.C. now owns 2,084 shares of the medical technology company's stock valued at $732,000 after purchasing an additional 28 shares during the period. KCM Investment Advisors LLC raised its stake in Stryker by 1.5% during the 4th quarter. KCM Investment Advisors LLC now owns 1,857 shares of the medical technology company's stock valued at $653,000 after acquiring an additional 28 shares in the last quarter. Rossby Financial LCC boosted its position in Stryker by 6.6% during the 4th quarter. Rossby Financial LCC now owns 451 shares of the medical technology company's stock worth $159,000 after acquiring an additional 28 shares during the period. Tcfg Wealth Management LLC grew its stake in shares of Stryker by 2.7% in the third quarter. Tcfg Wealth Management LLC now owns 1,091 shares of the medical technology company's stock worth $403,000 after purchasing an additional 29 shares in the last quarter. Finally, ICW Investment Advisors LLC increased its holdings in shares of Stryker by 0.6% during the fourth quarter. ICW Investment Advisors LLC now owns 5,096 shares of the medical technology company's stock valued at $1,791,000 after purchasing an additional 30 shares during the period. Institutional investors own 77.09% of the company's stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. Citigroup reaffirmed a "buy" rating on shares of Stryker in a report on Thursday, August 13th. JPMorgan Chase & Co. dropped their price target on shares of Stryker from $400.00 to $350.00 and set an "overweight" rating on the stock in a research report on Friday, July 31st. Piper Sandler reduced their price target on shares of Stryker from $420.00 to $390.00 and set an "overweight" rating for the company in a research note on Friday, July 31st. Wolfe Research cut shares of Stryker from an "outperform" rating to a "peer perform" rating in a report on Thursday, August 13th. Finally, Truist Financial raised their price objective on shares of Stryker from $330.00 to $340.00 and gave the company a "hold" rating in a research note on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $386.28.

Stryker Stock Performance

Shares of NYSE SYK opened at $308.07 on Friday. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59. The stock has a market capitalization of $118.17 billion, a price-to-earnings ratio of 31.92, a PEG ratio of 1.95 and a beta of 0.76. The stock's fifty day simple moving average is $329.43 and its 200 day simple moving average is $329.92. Stryker Corporation has a 52-week low of $281.00 and a 52-week high of $396.86.

Stryker (NYSE:SYK - Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share for the quarter, beating analysts' consensus estimates of $3.49 by $0.20. The business had revenue of $6.59 billion during the quarter, compared to analyst estimates of $6.58 billion. Stryker had a return on equity of 23.63% and a net margin of 14.43%.Stryker's revenue for the quarter was up 9.4% on a year-over-year basis. During the same quarter last year, the company posted $3.13 EPS. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. As a group, sell-side analysts forecast that Stryker Corporation will post 15.03 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a $0.88 dividend. This represents a $3.52 annualized dividend and a dividend yield of 1.1%. The ex-dividend date is Wednesday, September 30th. Stryker's dividend payout ratio (DPR) is presently 36.48%.

Insider Transactions at Stryker

In other news, insider Dylan Crotty sold 441 shares of the business's stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $328.61, for a total transaction of $144,917.01. Following the sale, the insider owned 6,102 shares in the company, valued at $2,005,178.22. The trade was a 6.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Debra King sold 826 shares of the company's stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $336.30, for a total transaction of $277,783.80. Following the completion of the sale, the insider owned 6,210 shares of the company's stock, valued at approximately $2,088,423. This trade represents a 11.74% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 351,267 shares of company stock valued at $118,197,701 over the last ninety days. Corporate insiders own 4.60% of the company's stock.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source